共 50 条
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
被引:309
|作者:
Kmiecik, Justyna
[1
]
Poli, Aurelie
[1
]
Brons, Nicolaas H. C.
Waha, Andreas
[2
]
Eide, Geir Egil
[3
,4
]
Enger, Per Oyvind
[5
]
Zimmer, Jacques
Chekenya, Martha
[1
,6
]
机构:
[1] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway
[2] Univ Hosp, Dept Neuropathol, Bonn, Germany
[3] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway
[4] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway
[5] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[6] Univ Bergen, Dept Clin Dent, N-5009 Bergen, Norway
关键词:
GBM;
Tumor infiltrating cells;
Regulatory T cells;
Antigen presenting cells;
REGULATORY T-CELLS;
MGMT PROMOTER METHYLATION;
NATURAL-KILLER-CELLS;
NK CELLS;
ADJUVANT TEMOZOLOMIDE;
PROGNOSTIC VALUE;
RECEPTOR;
CANCER;
EXPRESSION;
NKG2D;
D O I:
10.1016/j.jneuroim.2013.08.013
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
We characterized GBM patients' tumor and systemic immune contexture with aim to reveal the mechanisms of immunological escape, their impact on patient outcome, and identify targets for immunotherapy. Increased CD3 T-cell infiltration was associated with prolonged survival independent of age, MGMT promoter methylation and post-operative treatment that implies potential for immunotherapy for GBM. Several mechanisms of escape were identified: within the tumor microenvironment: induced cD8+cD28 Foxp3 Tre that may tolerize antigen presenting cells, elevated CD73 and CD39 ectonucleotidases that suppress T-cell function, and at the systemic level: elevated IL-10 levels in serum, diminished helper T-cell counts, and upregulated inhibitory CTLA-4. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:71 / 83
页数:13
相关论文